Global /Australia /Healthcare /Drug Manufacturers - Specialty & Generic /S66

Star Combo Pharma Ltd.

S66

• ASX: S66 • Delayed

0.2200AUD -2.2%

0.1550 USD

As of 6 June 2026, Star Combo Pharma Ltd. has a market cap of $21.21M USD, ranking #36713 globally and #1058 in Australia. It ranks #3297 in the Healthcare sector, and #199 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

36713

Country Rank

1058

Sector Rank

3297

Industry Rank

199

Key Stats

Market Cap

$21.21MUSD

29.72M AUD

Enterprise Value

$11.26MUSD

15.98M AUD

Revenue (TTM)

$17.12MUSD

23.99M AUD

EBITDA (TTM)

$4.83MUSD

6.86M AUD

Net Income (TTM)

$2.94MUSD

4.12M AUD

EBITDA Margin

29%

Profit Margin

22%

PE Ratio

7.2

PS Ratio

1.2

PB Ratio

0.8

EV/EBITDA

2.2

Company Profile

Country (HQ)

Australia

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Su Zhang open_in_new

Employees

Founded

2004

Website

starcombo.com.au open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-2.2%	-2.2%	2.3%	-8.3%	4.8%	-15%	91%	100%	-19%

News

Markets

Exchange	Ticker	Price	Quotes
Australian Securities Exchange (ASX) MIC: XASX PRIMARY	S66 Star Combo Pharma Ltd Ordinary Shares ISIN: AU0000004798 Shares Out.: Shares Outstanding: 135.003M¹ Shares Float: 30.518M² TV: TradingView: ASX: S66 SA: Stock Analysis: ASX: S66 YF: Yahoo Finance: S66.AX GF: Google Finance: ASX: S66 BA: Barron's: S66 MS: Morningstar: XASX: S66	0.2200 AUD	TV: TradingView: ASX: S66 SA: Stock Analysis: ASX: S66 YF: Yahoo Finance: S66.AX GF: Google Finance: ASX: S66 BA: Barron's: S66 MS: Morningstar: XASX: S66

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Star Combo Pharma Ltd.

Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products. It also provides its products through e-commerce platform to Chinese health product consumers. The company sells its products under the Costar, Living Healthy, Amax, and J&K brands. Star Combo Pharma Limited was founded in 2004 and is based in Smithfield, Australia.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Australia)

Name	Market Cap (USD) diff.	PE	Country
Neuren Pharmaceuticals Ltd. ASX: NEU	$1.11B 1.55B AUD 5K%	52.7	Australia
Actinogen Medical Ltd. ASX: ACW	$123.03M 172.39M AUD 480%	-	Australia
Clover Corporation Ltd. ASX: CLV	$114.37M 160.26M AUD 439%	18.1	Australia
Vita Life Sciences Ltd. ASX: VLS	$100.03M 140.17M AUD 372%	14.1	Australia
Paradigm Biopharmaceuticals Ltd. ASX: PAR	$56.42M 79.06M AUD 166%	-	Australia
Beroni Group Ltd. OTCMKTS: BNIGF	$49.41M 133%	-	Australia

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 177K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 139K%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 75K%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 52K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 52K%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 43K%	80.6	China

chevron_leftBack